ARCHIVES

Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 6 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

ASCO To Open Abstracts To Everyone Prior To Annual Meeting.

November 16, 2007

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981

NCI “Much Stronger” Now, Rimer Says In Note To Staff.

September 21, 2001

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006